Floatz logo

Nicergoline

Dysphagia

Phramongkutklao College of Medicine and HospitalSmall moleculePhase 3Active
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
41/ 100
Competitive Position
89/ 100

Competitive context

6 Active assets in the Dysphagia cohort.

Asset / SponsorPhaseRating
Nerve Growth Factor
The Third Affiliated hospital of Zhejiang Chinese Medical University
Phase 4BB
Modafinil
University of Arkansas
Phase 2B
Manuka Honey In Liquid Form
Radiation Therapy Oncology Group
Phase 2B
Carboplatin
Swedish Orphan Biovitrum
Phase 2B
Palifermin
Swedish Orphan Biovitrum
Phase 2B

View all 15 →

Same molecule, other indications

Nicergoline is also rated in:

anxiety disorderDormant
CCC
Indicative ·
54 / 100
View asset →
physiological malfunction arising from mental factorDormant
CCC
Indicative ·
54 / 100
View asset →
dementiaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →